Your browser doesn't support javascript.
loading
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Hüllein, Jennifer; Slabicki, Mikolaj; Rosolowski, Maciej; Jethwa, Alexander; Habringer, Stefan; Tomska, Katarzyna; Kurilov, Roma; Lu, Junyan; Scheinost, Sebastian; Wagener, Rabea; Huang, Zhiqin; Lukas, Marina; Yavorska, Olena; Helfrich, Hanne; Scholtysik, René; Bonneau, Kyle; Tedesco, Donato; Küppers, Ralf; Klapper, Wolfram; Pott, Christiane; Stilgenbauer, Stephan; Burkhardt, Birgit; Löffler, Markus; Trümper, Lorenz H; Hummel, Michael; Brors, Benedikt; Zapatka, Marc; Siebert, Reiner; Kreuz, Markus; Keller, Ulrich; Huber, Wolfgang; Zenz, Thorsten.
Afiliación
  • Hüllein J; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Slabicki M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Rosolowski M; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Jethwa A; Department for Statistics and Epidemiology, Institute for Medical Informatics, Leipzig, Germany.
  • Habringer S; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Tomska K; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Kurilov R; III. Medical Department of Hematology and Medical Oncology, Technical University of Munich, Germany.
  • Lu J; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Scheinost S; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.
  • Wagener R; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Huang Z; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Lukas M; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Germany.
  • Yavorska O; Institute of Human Genetics, University of Kiel, Kiel, Germany.
  • Helfrich H; Division of Molecular Genetics, DKFZ, Heidelberg, Germany.
  • Scholtysik R; Molecular Therapy in Hematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Bonneau K; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Tedesco D; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Küppers R; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Essen, Germany, and the German Cancer Consortium (DKTK).
  • Klapper W; Cellecta, Inc., Mountain View, California.
  • Pott C; Cellecta, Inc., Mountain View, California.
  • Stilgenbauer S; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Essen, Germany, and the German Cancer Consortium (DKTK).
  • Burkhardt B; Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel, Kiel, Germany.
  • Löffler M; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Trümper LH; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Hummel M; Department of Pediatric Hematology and Oncology, NHL-BFM Study Center, University Children's Hospital, Münster, Germany.
  • Brors B; Department for Statistics and Epidemiology, Institute for Medical Informatics, Leipzig, Germany.
  • Zapatka M; Department of Hematology and Medical Oncology, Göttingen University Medical Center, Göttingen, Germany.
  • Siebert R; Institute of Pathology, Charité-University Medicine Berlin, Berlin, Germany.
  • Kreuz M; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.
  • Keller U; Division of Molecular Genetics, DKFZ, Heidelberg, Germany.
  • Huber W; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Germany.
  • Zenz T; Institute of Human Genetics, University of Kiel, Kiel, Germany.
Cancer Res ; 79(12): 3125-3138, 2019 06 15.
Article en En | MEDLINE | ID: mdl-31000522
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 1 / Regulación Neoplásica de la Expresión Génica / Aberraciones Cromosómicas / Proteínas Proto-Oncogénicas / Linfoma de Burkitt / Proteínas de Ciclo Celular / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 1 / Regulación Neoplásica de la Expresión Génica / Aberraciones Cromosómicas / Proteínas Proto-Oncogénicas / Linfoma de Burkitt / Proteínas de Ciclo Celular / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania